Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $105,028 - $136,995
4,021 Added 4.91%
85,966 $2.93 Million
Q1 2024

May 14, 2024

BUY
$26.64 - $40.31 $585,360 - $885,731
21,973 Added 36.64%
81,945 $2.88 Million
Q4 2023

Feb 13, 2024

BUY
$19.95 - $31.0 $27,989 - $43,493
1,403 Added 2.4%
59,972 $1.73 Million
Q3 2023

Nov 15, 2023

BUY
$21.33 - $59.42 $158,012 - $440,183
7,408 Added 14.48%
58,569 $1.34 Million
Q2 2023

Aug 11, 2023

BUY
$34.33 - $62.11 $673,417 - $1.22 Million
19,616 Added 62.18%
51,161 $2.93 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $157,100 - $294,087
6,040 Added 19.15%
37,585 $1.41 Million
Q4 2022

Aug 11, 2023

SELL
$24.14 - $30.37 $3,138 - $3,948
-130 Reduced 0.41%
31,545 $843,000
Q4 2022

Feb 13, 2023

SELL
$24.14 - $30.37 $3,138 - $3,948
-130 Reduced 0.41%
31,545 $843,000
Q3 2022

Aug 11, 2023

SELL
$22.23 - $33.37 $11,070 - $16,618
-498 Reduced 1.55%
31,675 $896,000
Q3 2022

Nov 03, 2022

SELL
$22.23 - $33.37 $11,070 - $16,618
-498 Reduced 1.55%
31,675 $890,000
Q2 2022

Aug 11, 2023

BUY
$19.74 - $43.01 $141,831 - $309,026
7,185 Added 28.75%
32,173 $698,000
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $141,831 - $309,026
7,185 Added 28.75%
32,173 $687,000
Q1 2022

Aug 11, 2023

SELL
$36.25 - $52.02 $456,641 - $655,295
-12,597 Reduced 33.52%
24,988 $1 Million
Q1 2022

May 20, 2022

BUY
$36.25 - $52.02 $508,696 - $729,996
14,033 Added 128.1%
24,988 $1.01 Million
Q4 2021

Feb 16, 2022

BUY
$43.27 - $65.72 $5,798 - $8,806
134 Added 1.24%
10,955 $522,000
Q3 2021

Nov 12, 2021

SELL
$53.61 - $67.5 $64,332 - $81,000
-1,200 Reduced 9.98%
10,821 $613,000
Q2 2021

Aug 12, 2021

BUY
$45.13 - $64.99 $161,836 - $233,054
3,586 Added 42.51%
12,021 $690,000
Q1 2021

May 03, 2021

SELL
$29.77 - $84.85 $16,046 - $45,734
-539 Reduced 6.01%
8,435 $534,000
Q4 2020

Feb 12, 2021

BUY
$25.66 - $34.55 $6,312 - $8,499
246 Added 2.82%
8,974 $301,000
Q2 2020

Aug 10, 2020

BUY
$12.65 - $29.57 $110,409 - $258,086
8,728 New
8,728 $235,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.